These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 17593511)
21. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis]. Ito C; Ando Y; Akimoto T; Kusano E; Asano Y Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918 [TBL] [Abstract][Full Text] [Related]
22. Retrospective analysis of long-term lipid apheresis at a single center. Koziolek MJ; Hennig U; Zapf A; Bramlage C; Grupp C; Armstrong VW; Strutz F; Müller GA Ther Apher Dial; 2010 Apr; 14(2):143-52. PubMed ID: 20438535 [TBL] [Abstract][Full Text] [Related]
23. [Therapeutic apheresis in idiopathic nephrotic syndrome]. Moriconi L G Ital Nefrol; 2012; 29 Suppl 54():S67-72. PubMed ID: 22388834 [TBL] [Abstract][Full Text] [Related]
24. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy. Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422 [TBL] [Abstract][Full Text] [Related]
25. [The clinical efficacy of plasmapheresis in the combined therapy of patients with chronic glomerulonephritis and nephrotic syndrome]. Kolesnik NA; Dudar' IA; Velichko MB Urol Nefrol (Mosk); 1993; (6):44-6. PubMed ID: 8160322 [TBL] [Abstract][Full Text] [Related]
26. Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function. Muso E; Sakai S; Ogura Y; Yukawa S; Nishizawa Y; Yorioka N; Saito T; Mune M; Sugiyama S; Iino Y; Hirano T; Hattori M; Watanabe T; Yokoyama H; Sato H; Uchida S; Wada T; Shoji T; Oda H; Mori K; Kimura H; Ito O; Nishiyama A; Maruyama S; Inagi R; Fujimoto S; Tsukamoto T; Suzuki Y; Honda H; Babazono T; Tsuruya K; Yuzawa Y Ther Apher Dial; 2022 Feb; 26(1):220-228. PubMed ID: 34057286 [TBL] [Abstract][Full Text] [Related]
27. The ABC of apheresis. Dierickx D; Macken E Acta Clin Belg; 2015 Apr; 70(2):95-9. PubMed ID: 25366579 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic Plasmapheresis: A Revision of Literature. Altobelli C; Anastasio P; Cerrone A; Signoriello E; Lus G; Pluvio C; Perna AF; Capasso G; Simeoni M; Capolongo G Kidney Blood Press Res; 2023; 48(1):66-78. PubMed ID: 36481657 [TBL] [Abstract][Full Text] [Related]
29. Physiological role of plasma and its components and the clinical implications of different methods of apheresis: A narrative review. Ahmadpoor P; Aglae C; Cariou S; Pambrun E; Renaud S; Garo F; Darmon R; Schultz C; Prelipcean C; Reboul P; Moranne O Ther Apher Dial; 2021 Jun; 25(3):262-272. PubMed ID: 32710797 [TBL] [Abstract][Full Text] [Related]
30. [The indication of steroid pulse therapy and apheresis therapy for multiple sclerosis]. Ohji S; Nomura K Nihon Rinsho; 2008 Jun; 66(6):1127-32. PubMed ID: 18540358 [TBL] [Abstract][Full Text] [Related]